Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors

Pilot Study to Develop a Group-Based E-Health Intervention for Young Adult Cancer Survivors

Investigators will test an evidence-based behavioral intervention that is responsive to Young Adults (YA's) expressed needs and priorities

Study Overview

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tampa, Florida, United States, 33612
        • Moffitt Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-39 years old
  • Diagnosed with cancer between 18-39 years old
  • Cancer diagnosis was non-metastatic
  • Completed cancer treatment between 1 month and 5 years prior to enrollment, with the exception of ongoing hormone therapy
  • No documented or observable psychiatric or neurological disorders that could interfere with participation (e.g., active psychosis, active substance abuse), as identified by the referring medical team, chart review, or screening
  • Able to speak and read English
  • Able to provide informed consent

Exclusion Criteria:

  • Metastatic disease
  • Continued cancer treatment
  • Psychiatric or neurological disorders that could interfere with study participation
  • Vulnerable populations will not be included

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: eHealth
Weekly video conference groups led by a trained facilitator
Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and will be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction assessed by study-specific survey during the intervention - Acceptability
Time Frame: During intervention
The intervention will be deemed acceptable if, on average, participants report satisfaction with the weekly sessions as ≥2 on a 0-4 scale.
During intervention
Satisfaction assessed by study-specific survey after the intervention - Acceptability
Time Frame: Immediately after the intervention
The intervention will be deemed acceptable if, on average, participants report satisfaction with the overall program and intent to continue using the intervention skills as ≥2 on a 0-4 scale.
Immediately after the intervention
Session attendance after the intervention - Acceptability
Time Frame: Immediately after the intervention
Videoconference delivery will be acceptable if average group attendance is ≥6/10 sessions.
Immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life before intervention
Time Frame: Baseline
Participants will complete the 27-item Functional Assessment of Cancer Therapy - General
Baseline
Change in quality of life at after intervention
Time Frame: Immediately after intervention
Participants will complete the 27-item Functional Assessment of Cancer Therapy - General
Immediately after intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptom burden before intervention
Time Frame: Baseline
Participants will complete the 22-item Impact of Event Scale-Revised
Baseline
Change in Symptom burden after intervention
Time Frame: Immediately after intervention
Participants will complete the 22-item Impact of Event Scale-Revised
Immediately after intervention
Cancer-related distress before intervention
Time Frame: Baseline
Participants will complete the 22-item Impact of Event Scale-Revised
Baseline
Change in cancer-related distress after intervention
Time Frame: Immediately after intervention
Participants will complete the 22-item Impact of Event Scale-Revised
Immediately after intervention
Stress management skills self-efficacy before intervention
Time Frame: Baseline
Participants will complete subscales from the Measure of Current Status
Baseline
Change in stress management skills self-efficacy after intervention
Time Frame: Immediately after intervention
Participants will complete subscales from the Measure of Current Status
Immediately after intervention
Coping before intervention
Time Frame: Baseline
Participants will complete the Brief-COPE
Baseline
Change in coping after intervention
Time Frame: Immediately after intervention
Participants will complete the Brief-COPE
Immediately after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2021

Primary Completion (Actual)

January 6, 2022

Study Completion (Actual)

January 6, 2022

Study Registration Dates

First Submitted

August 31, 2021

First Submitted That Met QC Criteria

September 8, 2021

First Posted (Actual)

September 17, 2021

Study Record Updates

Last Update Posted (Actual)

April 14, 2023

Last Update Submitted That Met QC Criteria

April 13, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MCC-21053

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivor

Clinical Trials on Cognitive-Behavioral Stress Management and Health Education

Subscribe